Another bad call by jefferson1964
Don't worry, these who bought today will be rewarded. The stock should rebound back to 1.6's and today's breakout may support this rebound.
http://seekingalpha.com/currents/post/952631
Sentiment: Buy
On that day, OMER jumped 35%. Why? because OMER has reported positive data from its Phase 3 clinical trial evaluating OMS302. What was the price then? $10.22. Quick conclusion: the street saw this product as a money maker. Nothing has changed regarding OMS302 since then, so why the stock is below $4? because the company is raising cash at the market (ATM). Quick conclusion: after this financial overhang will be behind, these prices will be history. HINT: it won't be forever. Good luck!
Sentiment: Buy
These are the best news lately. I have much respect to Ingalls & Snyder.
Only 300 shares...
I think you named it. When the company will show a good cash position, investors will join and shorts will be covered. rrtzrealmd is right about one and only thing, this ATM is sucks. They could raise cash from the public in the old fashion way, and with less damage.
Sentiment: Strong Buy
Well, he wrote in that article, "I believe Omeros shares are worth $6.85 today". Well, I take 45% gains. Thanks!
Look for it on twitter..
Sentiment: Strong Buy